FreeTheAI

Bioxytran Finishes Production of Two New Dietary Supplements

NeutralLow impact
BIXT$0.0224 −3.95%

Bioxytran, Inc. (OTC: BIXT) finished manufacturing inventory for two new dietary supplements, V-LO and A-SUQAR, marking a step toward commercial sales. V-LO is a plant-based chewable tablet designed to support normal immune function, while A-SUQAR is designed to support healthy post-meal blood sugar levels that are already in a normal range.

The move into consumer products establishes a commercial revenue opportunity separate from the clinical-stage biotechnology company's main pharmaceutical research activities. Bioxytran previously established a distribution partnership with Khoury Medical LTD in February 2026 to bring A-SUQAR to markets in the Middle East.

The company is currently finalizing its sales, marketing, and distribution plans across retail, e-commerce, and regional partners. Exact launch timing and product availability will be announced after go-to-market arrangements are finalized.

Key points

  • Bioxytran, Inc. (OTC: BIXT) completed production of finished inventory for dietary supplements V-LO and A-SUQAR.
  • V-LO supports normal immune health, while A-SUQAR supports healthy post-meal blood sugar levels within normal range.
  • The commercial supplement business operates separately from Bioxytran's clinical-stage pharmaceutical pipeline.
  • Bioxytran holds a distribution deal with Khoury Medical LTD for Middle East distribution of A-SUQAR.
  • Go-to-market plans covering e-commerce and retail channels are being finalized prior to setting launch dates.

Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org

How we writeDisclaimer

Questions and answers

What products did Bioxytran finish manufacturing?

Bioxytran completed production of finished inventory for V-LO, an immune health supplement, and A-SUQAR, a supplement designed to support healthy post-meal blood sugar levels.

How will Bioxytran sell V-LO and A-SUQAR?

Bioxytran is finalizing go-to-market plans across e-commerce, retail, and distribution partners. It also holds a commercial distribution agreement with Khoury Medical LTD for A-SUQAR in the Middle East.

Is Bioxytran dropping its pharmaceutical programs?

No. Bioxytran operates its consumer dietary supplement business separately from its core pharmaceutical development programs.